Latest Breaking News On - Iologicale vaccine news - Page 1 : comparemela.com

URL copied Centre finalises advance deal with Hyderabad-based firm for 30 crore Covid vaccine doses The Union Ministry of Health has finalised arrangements with Hyderabad based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses. These vaccine doses will be manufactured and stockpiled by M/s Biological-E from August-December 2021.  For this purpose, the Union Ministry of Health would be making an advance payment of Rs. 1500 crore to M/s Biological-E.  The COVID-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trial after showing promising results in Phase 1 and 2 clinical trials. The vaccine being developed by Biological-E is a RBD protein sub-unit vaccine and is likely to be available in the next few months. 

Andhra pradeshResearch institute translational health science technologyUnion ministry of healthNational expert group on vaccine administrationVaccine development missionResearch developmentDepartment of biotechnologyImage sourceUnion ministryNational expert groupVaccine administrationDevelopment missionBiological eCovid vaccineBiologicale vaccineBiologicale covid vaccine